banner
MAO inhibitor, Salsolidine, Purity ≥98%
Inquiry

Cat. No.: X24-09-YM155

MAO inhibitor, Salsolidine, Purity ≥98%

Synonym: 5784-74-7; 6; 7-Dimethoxy-1-methyl-1; 2; 3; 4-tetrahydroisoquinoline; 6,7-Dimethoxy-1-methyl-1,2,3,4-tetrahydroisoquinoline; MAO inhibitor

  • MDL: MFCD00694774
  • CAS Number: 5784-74-7
  • Compound CID: 10302
img
Product Size
50 mg; 100 mg; 200 mg; 500 mg
Price
Datasheet
MSDS
Properties
Description
Salsolidine is an effective metabolism inhibitor, that has the ability to prevent the pathway of cell metabolism by inhibiting MAO. The molecular weight of the compound is 207.27, and its molecular formula is C12H17NO2.
Molecular Weight
207.27
Molecular Formula
C12H17NO2
Form
Lyophilized powder
Purity
≥98%
Impurities
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.
Identity
Confirmed by NMR/HPLC/MS.
Applications
Salsolidine displays the significant potential to act as an effective stereoselective inhibitor, which might provide insights into selective MAO-A inhibition and its effects.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0